✦ LIBER ✦

Æ-941, an inhibitor of angiogenesis: rationale for development in combination with induction chemotherapy/radiotherapy in patients with non-small-cell lung cancer (nsclc)

✍ Scribed by W.K. Evans; J. Latreille; G. Batist; P. Falardeau; P. Champagne; M. Rivière; E. Dupont

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-519 Concomitant chemo-radiotherapy fol

✍ Kosmidis, P.; Fountzilas, G.; Samantas, E.; Dimopoulos, A.; Goga, H.; Skarlos, D 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Induction chemotherapy with paclitaxel p

✍ Pallarés, C.; Capdevila, J.; Paredes, A.; Farré, N.; Ciria, J.P.; Membrive, I.; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 215 KB

A phase 1 trial of the MEK1/2 inhibitor

✍ Koh, P. Keng; Califano, R.; Dean, E.; Kosmin, J.; Ataman, O.; Jackson, A.; Black 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 97 KB

1208 POSTER Phase I and Pharmacokinetic

✍ H. Yoshioka; I. Okamoto; K. Takeda; M. Satouchi; N. Yamamoto; T. Seto; K. Kasaha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Quality assurance of thoracic radiothera

✍ Gijsbert W.P.M. Kramer; Catherine L. Legrand; Paul van Schil; Lon Uitterhoeve; E 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Docetaxel and concurrent radiotherapy af

✍ Vergnenègre, A.; Daniel, C.; Léna, H.; Fournel, P.; Kleisbauer, J.P.; Caer, H. L 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 174 KB